WINTON GROUP Ltd - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$519,000
+45.4%
23,607
-11.4%
0.03%
+52.6%
Q2 2021$357,000
+72.5%
26,655
+31.1%
0.02%
+58.3%
Q1 2021$207,000
+200.0%
20,328
+24.1%
0.01%
+140.0%
Q4 2020$69,000
-6.8%
16,375
-42.2%
0.01%
+150.0%
Q3 2020$74,00028,3380.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders